Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from U.S. medical centres

Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from U.S. medical centres

Background: Despite availability of ceftolozane-tazobactam (C/T) and ceftazidime-avibactam (CZA) for several years, the individual spectrum of activity of each agent may not be widely known. We compared the activity of C/T and CZA against convenience samples of 119 extended-spectrum β-lactamase (ESB...

Full description

Bibliographic Details
Main Authors: Elizabeth B. Hirsch, Hunter V. Brigman, Paola C. Zucchi, Alice Chen, Jadyn C. Anderson, George M. Eliopoulos, Nicole Cheung, Adam Gilbertsen, Ryan C. Hunter, Christopher L. Emery, Tiffany E. Bias
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
ESBL
Multidrug-resistant
MDR
beta-lactamase
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716520301090

Internet

http://www.sciencedirect.com/science/article/pii/S2213716520301090

Similar Items